the most important factors indicating a benefit from adjuvant chemotherapy on survival were greater than or equal to 5 sites of involvement , including those above and below the diaphragm ( p = .15 ) and extensive splenic involvement ( more than four nodules detected in the splenectomy specimen ) ( p = .15 ) .
C0037993
splenic
C0037995
splenectomy